首頁 > 市場調查報告書 > 製藥 > 動物用醫藥 > 全球動物醫療用產品（動物用藥品、疫苗、OTC藥、能力提昇藥）

聯絡我們?

市場調查報告書

全球動物醫療用產品（動物用藥品、疫苗、OTC藥、能力提昇藥）

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)

出版商	Kalorama Information
出版日期	2009年05月	商品編碼	86309
內容資訊	英文 160 pages
價格	US $ 3500 PDF by E-mail (Single User License) US $ 3900 Hard Copy US $ 7000 PDF by E-mail (Global Site License)

簡介
目錄
相關商品

全球動物醫療用產品（動物用藥品、疫苗、OTC藥、能力提昇藥） 是由出版商Kalorama Information在2009年05月所出版的。這份英文市場調查報告書包含160 pages 價格從美金3500起跳。

簡介

本報告書內容包括：動物用藥品、OTC藥、能力提昇藥、動物用疫苗等各市場區隔的機會及參與企業及新進入企業概要、2014年之前的市場預測、美國、歐洲等地的收益。內容網要摘記如下：

第1章動物用藥品市場：策略性預測

復健市場
流行病學
動物用藥品產業結構
市場
市場區隔
顧客區隔
市場規模及成長
地區別動向
競爭
收購及合併
研發
未來產業發展動向

第2章動物藥品市場

背景
市場規模及成長
市場區隔
競爭
主要市場動向

第3章動物用疫苗市場

背景
動物疾病及疫苗接種
疫苗的優點
病気的成本
疫苗開發
疫苗接種指南
市場規模及成長
地區別動向
競爭市佔率
疫苗開發戰
法規限制層面
疫苗整合方針相關國際合作
動物用疫苗的授權程序
未來動向

第4章動物能力提昇藥市場

背景
飼料添加物
市場規模及成長
市場區隔
地區別動向
競爭
植入及注射
法規限制框架
安全性問題

第5章動物用OTC藥市場

背景
寵物數動向
市場規模及成長
市場區隔
市場發展促進因素
產品生命週期管理
法規限制問題

第6章企業介紹

圖表

The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades.

This report, World Veterinary Health Products, takes a look at veterinary health products for both companion (pet) animals, and production animals (livestock and poultry) and the opportunity for existing players and new entrants in three segments:

Pharmaceuticals (including Parasiticides, Anti-infectives, NSAIDS, Cardiovasculars, Hormones, CNS, Others)
Veterinary (Pet) OTC Products (Parasiticides, NSAIDS, Vitamins, GI Disorders, Cold and Cough, Others)
Performance Enhancers
Veterinary Vaccines

For each segment, the report includes pet and production animal demographic information, market forecasts to 2014, major products in the industry, trends affecting business planning, and competitive activity. Revenues are provided for U.S., Europe and Rest of World. This report profiles the following key companies in this industry: This report profiles the following key companies in this industry:

Alpharma Animal Health
Adisseo France S.A.S.
BASF International
Bayer Healthcare
Boehringer Ingelheim GmbH
DSM Nutritional Products, Inc.
Elanco Animal Health
Fort Dodge Animal Health
Heska Corporation
Intervet Schering Plough Animal Health
Merial Animal Health Ltd.
Novartis Animal Health Inc.
Virbac SA
Pfizer Animal Health
This report was constructed with secondary research into annual reports, government health data, trade and medical journals, supplemented with phone and email interviews with executives and experts in the industry. Interviews were used to test assumptions and fix forecasts in the report.

CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET- STRATEGIC PERSPECTIVES

1.1. A Resilient Market, Even in Downturns
1.2. Epidemiology
- Livestock
- Pets
1.3. Veterinary Health Products Industry Structure
- 1.3.1. Key Factors Affecting the Industry
  - a) Threat of Generics
  - b) Lack of innovation
  - c) Expectations
  - d) High dependence on the product
1.4. Market
1.5. Market Segments
- 1.5.1 Companion Animal Products (CAP
  - Pet Insurance Market
  - Factors affecting the growth of Pet Insurance
- 1.5.2. Food Animal Products (FAP)
  - a) Leading Growth Drivers
1.6. Customer Segments
- a) Veterinary Hospitals
- b) Farms
- c) Pet Owners
1.7. Market Size and Growth
1.8. Market Segments
- 1.8.1. Veterinary Pharmaceuticals Market
- 1.8.2. Veterinary Vaccines Market
- 1.8.3. Veterinary Performance Enhancers Market
1.9. Geography
1.10. Species
1.11. Competition
1.12. Mergers and Acquisitions
1.13. Research and Development
- a) Leading R&D trends in the Animal Health Industry
1.14. Future Industry trends for Growth
- a) Shift from product to market focus
- b) Enhanced focus on R&D
- c) Consolidation and Globalization

CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET

2.1. Background
- a) Preventative medicines
- b) Therapeutic Medicines
- c) Others
2.2. Market Size and Growth
2.3. Market Segments
- 2.3.1. Veterinary Anti-Infective Market
- 2.3.2. Veterinary Anti-inflammatory Products Market
- 2.3.3. Veterinary Cardiovascular Products Market
- 2.3.4. Veterinary Parasiticidal Products Market
- 2.3.5. Veterinary CNS disorders Products Market
- 2.3.6. Veterinary Hormonal Products Market
2.4. Competition
2.5. Leading Market Trends
- a) Generics threat
- b) New technologies and innovations
- c) New geographical market growth

CHAPTER THREE: VETERINARY VACCINES MARKET

3.1. Background
3.2. Veterinary Diseases & Vaccination
- 3.2.1. Vaccine Types
  - a) Live vaccines
  - b) Dead vaccines
- 3.2.2. Livestock Vaccination
  - a) Cattle Vaccines
  - b) Sheep Vaccines
  - c) Goat Vaccines
  - d) Pig Vaccines
  - e) Swine Vaccines
- 3.2.3. Pet vaccines
  - a) Background
  - b) Current guidelines
- 3.2.4. Poultry vaccines
3.3. Vaccination Advantages
- a) Cost containment
- b) Reduction in antibiotic use
- c) Improvement in human health
- d) Impact on the industry
- e) Good Health, consistent throughput
3.4. Disease costs
3.5. Vaccine development
- a) Development Process
- b) Equipment
3.6. Vaccination Guidelines
3.7. Market Size and Growth
3.8. Geographical split
3.9. Competitive Share
- a) Demand Drivers: Positive Factors
- b) Demand: Negative Factors
- 3.10. Hurdles in Vaccine Development
- a) Biological and technical obstacles
- b) Economic obstacles
- c) Target complexity and diversity
3.11. Regulatory Aspects
3.12. International Cooperation on Harmonization Guidelines for Vaccines
3.13. Procedures for licensing veterinary vaccines
- a) Japan
- b) United States of America
- c) European Union
- 3.14. Future Trends
- a) Emerging diseases
- b) New vaccine technologies

CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS MARKET

4.1. Background
4.2. Feed Additives
- 4.2.1. Feed Composition
- 4.2.2. Nutritional Feed Additives
  - a) Amino acids
  - b) Vitamins
  - c) Organic acids
- 4.2.3. Medicated Feed Additives
  - a) Enzymes
  - b) Prebiotics, Probiotics
  - c) Hormones
- 4.2.4. Feed Additives: Advantages
  - a) Improve animal diet.
  - b) Provide therapeutic benefit and reduce cost.
  - c) Increase feed conversion efficiency thereby leading to improved profitability.
4.3. Market size and growth
- 4.3.1. Market Growth Drivers
4.4. Market Segments
- 4.4.1. Nutritional Feed Additives Market
  - a) Amino acids
  - b) Vitamins
  - c) Organic Acids
- 4.4.2. Medicated Feed Additives Market
  - a) Antibiotics
  - b) Probiotics and Prebiotics
  - c) Enzymes
  - d) Anti-protozoal agents
- 4.4.2.1. Medicated Feed Additives: By Species (Poultry, Pigs, Cattle, Others), 2008
4.5. Geographical Split
4.6. Competition
4.7. Implants and Injections
- 4.7.1. Market Size and Growth
4.8. Regulatory Framework
- a) US
- b) Europe
4.9. Safety Issues

CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET

5.1. Background
5.2. Pet population trends
- a) Greying human populace
- b) Increasing life expectancy of pets
- c) Advantages
5.3. Market Size and Growth
5.4. Market Segments
5.5. Market Drivers
- a) Rising pet ownership
- b) Consumer behavior
- c) Rx-to-OTC switch
- d) Product quality
- e) Price sensitivity
- f) Improving distribution network
- g) Increasing focus on Wellness
5.6. Product Life-cycle Management
- a) Broad customer group
- b) New formulations
- c) Creative marketing strategies
- d) Distribution Structure
5.7. Regulatory Issues

CHAPTER SIX: CORPORATE PROFILES

6.1. Alpharma Animal Health
- Background
- Products
- Revenues
- Business Strategy
6.2. Adisseo France S.A.S.
- Background
- Products
- Business Strategy
- Revenues
6.3. BASF International
- Background
- Products
- Revenues
6.4. Bayer Healthcare
- Background
- Products
- Revenues
6.5. Boehringer Ingelheim GmbH
- Background
- Products
- Revenues
6.6. DSM Nutritional Products, Inc.
- Background
- Products
- Revenues
6.7. Elanco Animal Health
- Background
- Products
- Revenues
6.8. Fort Dodge Animal Health
- Background
- Products
- Revenues
6.9. Heska Corporation
- Background
- Products
- Revenue
6.10. Intervet Schering Plough Animal Health
- Background
- Products
- Products
- Revenues
6.11. Merial Animal Health Ltd.
- Background
- Products
- Revenues
6.12. Novartis Animal Health Inc.
- Background
- Products
- Farm animal products
- Livestock animal products
6.13. Virbac SA
- Background
- Revenues
- Products
6.14. Pfizer Animal Health
- Background
- Products
- Revenues

CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET STRATEGIC PERSPECTIVES

Exhibit 1: Worldwide Livestock Population, 2008
Exhibit 2: Worldwide Pet population, 2008
Exhibit 3: Market Share: Companion Animal vs. Food Production Animal
Exhibit 4: Worldwide Companion Animal Prescriptions and Vaccines Market, 2008
Exhibit 5: US Household Penetration of Pets (%), 2008
Exhibit 6: Worldwide Veterinary Health Products Market
Exhibit 7: Worldwide Veterinary Health Products Market: Market Segments ($ billion) and Growth (%) (2006-14)
Exhibit 8: Worldwide Veterinary Health Products Market:
Exhibit 9: Worldwide Veterinary Pharmaceuticals Market:
Exhibit 10: Worldwide Veterinary Pharmaceutical Products Market, 2006-14
Exhibit 11: Worldwide Veterinary Vaccines Market:
Exhibit 12: Veterinary Vaccines Market, 2006-14
Exhibit 13: Worldwide Veterinary Performance Enhancer Products Market:
Exhibit 14: Veterinary Performance Enhancers Market, 2006-14
Exhibit 15: Regional Share Break-up (%), 2008
Exhibit 16: Worldwide Veterinary Health Products Market:
Exhibit 17: Worldwide Veterinary Health Products Market by Region:
Exhibit 18: Veterinary Health Products Market by Species, 2008 (Ruminants, Pigs, Poultry, Companions, Others)
Exhibit 19: Veterinary Health Products Market: Leading Companies, 2008
Exhibit 20: Veterinary Health Products Industry: Mergers and Acquisitions Trends